This most recent twist inside the Lykos Therapeutics saga threatens a major overhaul of the organization’s system and course, with Musk ally and billionaire Trader Antonio Gracias appearing to choose to just take the business back towards its nonprofit drug development roots and a more Doblinite philosophy.A patent application from psychological